News

2019

company

year

domain

Quanterix Simoa Technology Unlocks Low-Level Markers Critical to Rapid Triage Test in Study for Active Pulmonary Tuberculosis

Quanterix 10.25.2019

Syros Announces New Data from Phase 2 Trial of SY-1425 in Combination with Azacitidine Demonstrating High Response Rates, Rapid Onset of Action and Favorable Tolerability Profile in RARA-Positive Newly Diagnosed Unfit AML Patients

Syros Pharmaceuticals 10.24.2019

Moderna Named Top Employer by Science for Fifth Consecutive Year

Moderna 10.24.2019

Axcella Enters into Collaboration with CYTOO to Explore Impact of Dysregulated Metabolism on Muscle Physiology

Axcella Therapeutics 10.23.2019

Moderna Receives FDA Fast Track Designation for Propionic Acidemia Program (mRNA-3927)

Moderna 10.22.2019

Kaleido Biosciences and Washington University School of Medicine to Collaborate on Exploring the Influence of Microbiome Metabolic Therapies (MMT™) on Physiology and Metabolism

10.22.2019

Kintai Therapeutics Announces the Appointment of Dr. Francesca Barone as Head of Experimental Medicine

10.21.2019

Syros Announces Update on Selective CDK7 Inhibitor Portfolio

Syros Pharmaceuticals 10.17.2019

Flagship Pioneering Unveils Cygnal Therapeutics

10.08.2019

Axcella Provides Progress Updates for Liver Program Candidates AXA1125 and AXA1957

Axcella Therapeutics 10.07.2019

Loading